CyDex Pharmaceuticals
1993
FOUNDED
M&A
STATUS
31-40
EMPLOYEES
M&A
LATEST DEAL TYPE
$35.5M
LATEST DEAL AMOUNT
Description
Provider of drug delivery technology. The company's drug delivery technology uses four Captisol-enabled products commercialized by Pfizer and Bristol-Myers Squibb (BMS) to address asthma, depression, allergy, cancer and arrhythmia disease states.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Parent Company
Primary Office
- 10513 West 84th Terrace
- Lenexa, KS 66214
- United States
+1 (913) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore CyDex Pharmaceuticals’s full profile, request a free trial.
CyDex Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 26-Jan-2011 | $35.5M | 0000 | 000.00 | Completed | Clinical Trials - Phase 2 |
| 4. Later Stage VC | 24-Mar-2010 | 000.00 | 0000 | Completed | Generating Revenue | |
| 3. IPO | 28-Oct-2008 | 0000 | Cancelled | Clinical Trials - Phase 2 | ||
| 2. Early Stage VC (Series B) | 17-Aug-2004 | $17M | $29M | 000.00 | Completed | Clinical Trials - Phase 2 |
| 1. Early Stage VC (Series A) | 11-Oct-2000 | $12M | $12M | 000.00 | Completed | Clinical Trials - Phase 2 |
CyDex Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 0,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 00 | 0.000 |
| Series A | 16,464,622 | $0.010000 | 7% | $0.73 | $0.73 | 1x | $0.73 | 15.99% |
CyDex Pharmaceuticals Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Clariden Investment | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Eastman Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Edelman Financial Services | Asset Manager | Minority | 000 0000 | 000000 0 | ||
| Lord Rothschild | Angel (individual) | Minority | 000 0000 | 000000 0 | ||
| Private Equity Direct Finance | PE/Buyout | Minority | 000 0000 | 000000 0 |